pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogs.
Leroux
J C
JC
School of Pharmacy, University of Geneva, Switzerland.
Cozens
R M
RM
Roesel
J L
JL
Galli
B
B
Doelker
E
E
Gurny
R
R
D000284:Administration, Oral; D000818:Animals; D002219:Carbamates / Q000008:administration & dosage* / Q000097:blood; D002626:Chemistry, Pharmaceutical; D004285:Dogs; D005069:Evaluation Studies as Topic; D005260:Female; D016333:HIV Protease / Q000187:drug effects; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000097:blood; D006863:Hydrogen-Ion Concentration; D007413:Intestinal Mucosa / Q000378:metabolism; D008297:Male; D009842:Oligopeptides / Q000008:administration & dosage* / Q000097:blood; D010316:Particle Size; D012680:Sensitivity and Specificity
D002219:Carbamates; D017320:HIV Protease Inhibitors; D009842:Oligopeptides; C098598:CGP 57813; D016333:HIV Protease